Can AI discover new biology?

It began with an unexpected result in an automated laboratory in Zhangjiang, Shanghai. In traditional drug discovery, laboratory capacity is tightly budgeted, and evaluating unconventional biological ideas is often viewed as an unjustifiable luxury. But when a bundle of in vivo studies we purchased through a contract research organization had more assay capacity than our programs needed, our neuroscience team decided to run a test. We turned to our AI target discovery platform, PandaOmics, to…